Bavarian Nordic stock jumps after U.S. orders 2.5 million more monkeypox vaccine doses
The U.S.-listed shares of Bavarian Nordic A/S jumped 2.0% in afternoon trading Friday, after the Denmark-based drug maker said the U.S. government has ordered 2.5 million additional doses of liquid-frozen JYNNEOS, the only monkeypox vaccine approved by the U.S. Food and Drug Administration. The new ...